1. Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children.
- Author
-
Hart JD, Edwards T, Burr SE, Harding-Esch EM, Takaoka K, Holland MJ, Sillah A, Mabey DC, and Bailey RL
- Subjects
- Anti-Bacterial Agents pharmacology, Azithromycin pharmacology, Child, Preschool, Chlamydia trachomatis, Follow-Up Studies, Gambia, Humans, Infant, Spleen pathology, Trachoma pathology, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Azithromycin therapeutic use, Spleen drug effects, Splenomegaly prevention & control, Trachoma drug therapy
- Abstract
Objective: To assess the effect of azithromycin mass drug administration regimens on spleen rates in children aged 0-5 years., Methods: Clinical assessment of spleen size was carried out during a cluster-randomised trial of azithromycin mass treatment for trachoma elimination in The Gambia. Twenty-four communities received three annual mass treatments with azithromycin, and 24 communities received treatment at baseline only., Results: At the 30-month follow-up, 3646 children aged 0-5 years had spleen examination and measurement. Palpable splenomegaly was significantly lower in annually treated vs. baseline-only treatment communities and in treated vs. untreated children at 24 months in the annual treatment arm., Conclusion: The results suggest an effect of azithromycin on spleen rates at the individual level and are most plausibly due to the antimalarial effects of azithromycin., (© 2014 John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF